SchizophreniaCare360 Podcasts

Podcasts

Do hallucinations automatically indicate a schizophrenia diagnosis?

09/30/2021

In his live Table Talk session at the Sana Symposium, Rick Doblin, PhD, Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS), answers the question of whether or not hallucinations automatically indicate...

In his live Table Talk session...

09/30/2021

Psych Congress Network

Podcasts

Discussing Long-Acting Injectable Antipsychotics for Patients with Schizophrenia

09/13/2021

In this podcast, Psych Congress Steering Committee member Rakesh Jain, MD, MPH facilitates a Q&A session with Leslie Citrome, MD, MPH, and Georgia Stevens, PhD, APRN, PMHCNS-BC, on their Psych Congress Regionals virtual series presentation...

In this podcast, Psych Congress...

09/13/2021

Psych Congress Network

Podcasts

Dr. Jonathan Meyer on Treating Schizophrenia: Lessons Learned and Future Directions

09/09/2020

In this podcast, Jonathan Meyer, MD, discusses the role of D2 antagonism in schizophrenia treatment, lessons learned about schizophrenia treatment from clozapine, and emerging treatments for schizophrenia and their therapeutic targets.

In this podcast, Jonathan Meyer,...

09/09/2020

Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

SchizophreniaCare360 Podcasts

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products